BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 23301979)

  • 21. Severe bleeding in surgical and trauma patients: the role of fibrinogen replacement therapy.
    Spahn DR
    Thromb Res; 2012 Dec; 130 Suppl 2():S15-9. PubMed ID: 23439002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma transfusion for patients with severe hemorrhage: what is the evidence?
    Callum JL; Rizoli S
    Transfusion; 2012 May; 52 Suppl 1():30S-7S. PubMed ID: 22578369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolonged prothrombin time after recombinant activated factor VII therapy in critically bleeding trauma patients is associated with adverse outcomes.
    McMullin NR; Wade CE; Holcomb JB; Nielsen TG; Rossaint R; Riou B; Rizoli SB; Kluger Y; Choong PI; Warren B; Tortella BJ; Boffard KD;
    J Trauma; 2010 Jul; 69(1):60-9. PubMed ID: 20622579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibrinogen concentrates for bleeding trauma patients: what is the evidence?
    Meyer MA; Ostrowski SR; Windeløv NA; Johansson PI
    Vox Sang; 2011 Oct; 101(3):185-90. PubMed ID: 21535437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal of trauma-induced coagulopathy using first-line coagulation factor concentrates or fresh frozen plasma (RETIC): a single-centre, parallel-group, open-label, randomised trial.
    Innerhofer P; Fries D; Mittermayr M; Innerhofer N; von Langen D; Hell T; Gruber G; Schmid S; Friesenecker B; Lorenz IH; Ströhle M; Rastner V; Trübsbach S; Raab H; Treml B; Wally D; Treichl B; Mayr A; Kranewitter C; Oswald E
    Lancet Haematol; 2017 Jun; 4(6):e258-e271. PubMed ID: 28457980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a massive transfusion protocol.
    Bormanis J
    Transfus Apher Sci; 2008 Feb; 38(1):57-63. PubMed ID: 18308636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coagulation management.
    Grottke O
    Curr Opin Crit Care; 2012 Dec; 18(6):641-6. PubMed ID: 23090566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Massive transfusion in the trauma patient: Continuing Professional Development.
    Hayter MA; Pavenski K; Baker J
    Can J Anaesth; 2012 Dec; 59(12):1130-45. PubMed ID: 23076727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of recombinant activated factor VII, prothrombin complex concentrate, and fibrinogen concentrate to reverse apixaban in a rabbit model of bleeding and thrombosis.
    Martin AC; Le Bonniec B; Fischer AM; Marchand-Leroux C; Gaussem P; Samama CM; Godier A
    Int J Cardiol; 2013 Oct; 168(4):4228-33. PubMed ID: 23928345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COMPARING THE EFFECTIVENESS OF CONCENTRATE OF ALL PROTHROMBIN COMPLEX FACTORS WITH RECOMBINANT HUMAN COAGULATION FACTOR VIIa IN THE TREATMENT OF BLEEDING AFTER CARDIAC SURGERY.
    Zagórski M; Sejboth J
    Pol Merkur Lekarski; 2023; 51(5):448-455. PubMed ID: 38069844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
    Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
    Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Coagulation management in trauma-related massive bleeding. - Recommendations of the Task Force for Coagulation (AGPG) of the Austrian Society of Anesthesiology, Resuscitation and Intensive Care Medicine (OGARI)].
    Fries D; Innerhofer P; Perger P; Gütl M; Heil S; Hofmann N; Kneifel W; Neuner L; Pernerstorfer T; Pfanner G; Schöchl H; Ziegler B; Kölblinger C; Kozek-Langenecker S
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2010 Sep; 45(9):552-61. PubMed ID: 20839143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential value of transfusion protocols in cardiac surgery.
    Görlinger K; Dirkmann D; Hanke AA
    Curr Opin Anaesthesiol; 2013 Apr; 26(2):230-43. PubMed ID: 23407150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prothrombin complex concentrate versus recombinant factor VIIa for reversal of hemodilutional coagulopathy in a porcine trauma model.
    Dickneite G; Dörr B; Kaspereit F; Tanaka KA
    J Trauma; 2010 May; 68(5):1151-7. PubMed ID: 19996804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Coagulopathy in multiple trauma: new aspects of therapy].
    Grottke O; Henzler D; Spahn DR; Rossaint R
    Anaesthesist; 2007 Jan; 56(1):95-106; quiz 107-8. PubMed ID: 17219186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The coagulopathy of massive transfusion.
    Hardy JF; de Moerloose P; Samama CM
    Vox Sang; 2005 Oct; 89(3):123-7. PubMed ID: 16146503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of new procoagulants in blunt and penetrating trauma.
    Peralta MR; Chowdary P
    Curr Opin Anaesthesiol; 2019 Apr; 32(2):200-205. PubMed ID: 30817396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Procedure for critical nonsurgical bleeding].
    Grottke O; Rossaint R
    Chirurg; 2007 Feb; 78(2):101-2, 104-9. PubMed ID: 17265055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prothrombin complex concentrate: an effective therapy in reversing the coagulopathy of traumatic brain injury.
    Joseph B; Hadjizacharia P; Aziz H; Kulvatunyou N; Tang A; Pandit V; Wynne J; O'Keeffe T; Friese RS; Rhee P
    J Trauma Acute Care Surg; 2013 Jan; 74(1):248-53. PubMed ID: 23271101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prothrombin complex concentrate for critical bleeding.
    Patanwala AE; Acquisto NM; Erstad BL
    Ann Pharmacother; 2011 Jul; 45(7-8):990-9. PubMed ID: 21730276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.